UBC Medical Indonesia Tbk. vs Medela Potentia Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Medela Potentia Tbk. trades at Rp208 (market cap 2.89T, 269K 24h volume). The key difference: Medela Potentia Tbk. is far larger — about 5× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 269K). Which is the better fit depends on your goals.
| LABS | MDLA | |
|---|---|---|
Market Cap | 576.7B | 2.89T |
Volume | 3.48M | 269K |
Lot | 34.82K | 2.69K |
Turnover | 522.79M | 55.76M |
Average Price | 150.13 | 207.28 |
Value | 522.79M | 55.76M |
Indicative Equilibrium Price | 148 | 208 |
Indicative Equilibrium Volume | 350 | 15 |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Medela Potentia Tbk. (Company) was established based on Deed of Establishment No. 04 dated August 5, 2011, of Public Notary Evy Ferdiana, S.H, Notary of Bekasi Regency, domiciled in Lemah Abang. The Company started its operation activities in 2013.
Read more on MDLA →